Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01506700 · ClinicalTrials.gov registry record

Real Time Optical Coherence Tomography (OCT) of Human Tissue

A clinical trial, sponsored by Diagnostic Photonics.

Terminated
Registry status
5
Enrollment target

NCT01506700: Clinical Trial study, sponsored by Diagnostic Photonics.

NCT01506700 is a clinical trial that was terminated before completion, run by Diagnostic Photonics. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01506700 was terminated before completion, sponsored by Diagnostic Photonics.

TERMINATED
Registry status
5 participants
Enrollment target

Study Summary

This is a single-arm, prospective, study of an optical imaging device on approximately twenty (20) subjects undergoing lumpectomies at one study site. In vivo and ex vivo imaging will be performed on study subjects with results being compared to final pathology.

Interventions

  • DEVICE Optical Coherence Tomography

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2012-05
Est. Completion 2019-07-17
Diagnostic Photonics

2 total trials

Why NCT01506700 stopped before completion

NCT01506700 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Optical Coherence Tomography is the first listed.

NCT01506700 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01506700 about?

NCT01506700 is a clinical study titled "Real Time Optical Coherence Tomography (OCT) of Human Tissue". This is a single-arm, prospective, study of an optical imaging device on approximately twenty (20) subjects undergoing lumpectomies at one study site. In vivo and ex vivo imaging will be performed on study subjects with results being compared to final pathology.

What is the current status of trial NCT01506700?

This trial is currently terminated. The enrollment target is 5 participants. The study started on 2012-05. Estimated completion is 2019-07-17.

What interventions are being tested in trial NCT01506700?

The interventions under investigation include: Optical Coherence Tomography (DEVICE).

Who is sponsoring clinical trial NCT01506700?

This trial is sponsored by Diagnostic Photonics, which has 2 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01506700, the US trial registry maintained by the National Library of Medicine. NCT01506700 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.